An NNI Symposium: HMOs: A window of opportunity or a strong weapon in strengthening immunity
person
Professor Lars Bode
Professor Ryan Carvalho
Prof. Yvan Vandenplas
Carine Blanchard
PhD
Sagar Thakkar
Topic(s):
Allergy
Gut Microbiota
Growth & Development
Summary
Human milk oligosaccharides (HMOs) are a group of complex carbohydrates that are highly abundant in human milk and contribute to shaping the infant’s gut microbiome and immune system for immediate and long-term health benefits. HMOs are the 3rd largest solid component of human milk and over 200 HMOs have been identified so far. 2’FL and LNnT are among the most studied HMOs with clinical evidence to support immunity and the developing microbiome, but latest research on additional HMOs show promise in expanded benefits on gut, immune, brain and bone health.
